A nurse is caring for a patient with acute heart failure who has been receiving IV furosemide for the past 24 hours. Which assessment finding should be the nurse's highest priority?

Serum potassium level of 2.8 mEq/L indicates hypokalemia, which increases the risk of cardiac arrhythmias, especially in patients with heart failure receiving furosemide. This is a critical finding requiring immediate intervention. Other options are less urgent: urine output of 30 mL/hr is acceptable, serum sodium of 135 mEq/L is normal, and blood pressure of 90/60 mmHg, while low, is not as immediately life-threatening as severe hypokalemia.

Understanding the Clinical Scenario
The patient has acute heart failure (AHF) and has been receiving intravenous (IV) furosemide, a loop diuretic, for 24 hours without clinical improvement. This lack of response to an adequate dose of a loop diuretic is the hallmark of diuretic resistance, a condition where the kidneys fail to achieve the expected natriuresis and diuresis despite escalating doses ^[4]. In AHF, congestion is the central pathophysiologic feature driving hospitalization, and effective decongestion is the primary goal of therapy ^[1]. When loop diuretic monotherapy fails, the nurse must recognize the need for an escalated strategy rather than simply repeating the same intervention.

Analysis of the Correct Answer (Option 1)
The priority intervention is to assess for signs of diuretic resistance and prepare to administer a thiazide diuretic in combination. This strategy is known as sequential nephron blockade. Loop diuretics like furosemide act on the thick ascending limb of the loop of Henle. Over time, the distal convoluted tubule can undergo compensatory hypertrophy and increase sodium reabsorption, blunting the effect of the loop diuretic. Adding a thiazide diuretic, which blocks the sodium-chloride cotransporter in the distal convoluted tubule, targets a second site in the nephron, synergistically overcoming this resistance [1,2]. A network meta-analysis of randomized clinical trials supports this approach, demonstrating that sequential nephron blockade with a thiazide added to furosemide is an effective strategy to improve decongestion in patients with diuretic resistance ^[3].

Critique of the Incorrect Options
- Option 2: Simply increasing the frequency of furosemide administration from twice daily to every 6 hours fails to address the underlying mechanism of diuretic resistance. If the nephron has adapted to block the drug's effect at its single site of action, providing more of the same drug will yield diminishing returns. The evidence compares continuous infusion versus bolus dosing of furosemide, but the core issue here is a lack of response to the drug class itself, not just the dosing interval [1,2].
- Option 3: Discontinuing the loop diuretic and switching to a potassium-sparing diuretic is inappropriate. Potassium-sparing diuretics, such as spironolactone, act on the collecting duct and have a relatively weak natriuretic effect. They are not effective as a primary decongestive agent in acute heart failure with significant fluid overload and diuretic resistance. This switch would leave the bulk of sodium reabsorption in the loop of Henle and distal tubule unopposed ^[4].
- Option 4: While fluid and sodium restriction are important non-pharmacologic components of heart failure management, they are not the priority intervention when a patient has demonstrated a poor response to IV diuresis over 24 hours. The immediate need is to establish effective pharmacologic decongestion to relieve symptoms and prevent further decompensation. Relying solely on restriction would delay necessary escalation of diuretic therapy [1,4].

Pathophysiology and Clinical Reasoning
Diuretic resistance in cardiorenal syndrome is multifactorial, involving pharmacokinetic limitations, tubular adaptations, and neurohormonal activation ^[4]. The nurse’s role is to monitor for objective signs of this resistance, such as inadequate hourly urine output (often defined as net fluid loss of less than 1-2 liters in 24 hours despite IV diuretics), persistent dyspnea, and ongoing weight gain or lack of weight loss ^[2]. Recognizing these cues and understanding the rationale for sequential nephron blockade allows the nurse to anticipate the next step in the medical plan, which is the addition of a thiazide diuretic like metolazone or hydrochlorothiazide. This collaborative intervention directly targets the pathophysiologic adaptation causing treatment failure, making it the clinical priority [1,3].